Humana (HUM) - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4448591028
Humana Inc., a leading health and well-being company in the U.S., operates through two main segments: Insurance and CenterWell. The company offers a wide range of medical and supplemental benefit plans to individuals. They are contracted with the Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program and work with various states to provide Medicaid, long-term support services, and dual eligible benefits.
In addition to these services, Humana provides fully insured medical and specialty health insurance benefits, including dental, vision, life insurance, and other supplemental health benefits to individuals and employer groups. Their offerings extend to military services via the TRICARE T2017 East Region contract and the management of a PBM business.
Furthermore, Humana offers comprehensive pharmacy solutions, provider services, and home solutions, such as home health services, to both its health plan members and third parties. Established in 1961 and headquartered in Louisville, Kentucky, Humana Inc. continues to be a key player in the healthcare industry. For more information, you can visit their website: https://www.humana.com
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
HUM Stock Overview
Market Cap in USD | 42,016m |
Sector | Healthcare |
Industry | Healthcare Plans |
GiC SubIndustry | Managed Health Care |
TER | 0.00% |
IPO / Inception | 1993-01-22 |
HUM Stock Ratings
Growth 5y | 3.24 |
Fundamental | 5.50 |
Dividend | 5.42 |
Rel. Performance vs Sector | -4.92 |
Analysts | 3.91/5 |
Fair Price Momentum | 355.74 USD |
Fair Price DCF | 690.64 USD |
HUM Dividends
Yield 12m | 1.09% |
Yield on Cost 5y | 1.51% |
Dividends CAGR 5y | 9.98% |
Payout Consistency | 49.9% |
HUM Growth Ratios
Growth 12m | -33.20% |
Growth Correlation 12m | -49% |
Growth Correlation 3m | -66% |
CAGR 5y | 6.76% |
Sharpe Ratio 12m | -1.19 |
Alpha vs SP500 12m | -54.91 |
Beta vs SP500 5y weekly | 0.93 |
ValueRay RSI | 54.78 |
Volatility GJR Garch 1y | 31.05% |
Price / SMA 50 | -5.4% |
Price / SMA 200 | -25.67% |
Current Volume | 1557.4k |
Average Volume 20d | 1813.6k |
External Links for HUM Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X (Twitter) • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of April 19, 2024, the stock is trading at USD 324.83 with a total of 1,557,433 shares traded.
Over the past week, the price has changed by +2.70%, over one month by -6.20%, over three months by -20.95% and over the past year by -36.11%.
According to ValueRays Forecast Model, HUM Humana will be worth about 391.8 in April 2025. The stock is currently trading at 324.83. This means that the stock has a potential upside of +20.62%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 408.4 | 25.7% |
Analysts Target Price | 587.5 | 80.9% |
ValueRay Target Price | 391.8 | 20.6% |